PRECIGEN, INC. — Director's Dealing 2014

Jan 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fibrocell Science, Inc. (FCSC)
CIK: 0000357097
Period of Report: 2014-01-24

Reporting Person: KIRK RANDAL J (10% Owner)
Reporting Person: INTREXON CORP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-24	Common Stock	P	1024590	$4.88	Acquired	6024915	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9219512	Indirect

Footnotes

F1: Shares were issued on January 24, 2014 as partial consideration in connection with the Second Amendment to the Exclusive Channel Collaboration Agreement dated January 10, 2014 between the issuer and Intrexon Corporation pursuant to a Supplemental Stock Issuance Agreement dated January 10, 2014 between the issuer and Intrexon Corporation.

F2: Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Shares held by Intrexon Corporation may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

F3: Randal J. Kirk controls NRM VII Holdings I, LLC ("NRM VII Holdings"). Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.